nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adoptive T cell immunotherapy for medullary thyroid carcinoma targeting GDNF family receptor alpha 4
|
Bhoj, Vijay G. |
|
|
20 |
C |
p. 387-398 |
artikel |
2 |
A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer
|
Wang, Na |
|
|
20 |
C |
p. 71-81 |
artikel |
3 |
Anthony N. van den Pol (1949–2020)
|
Lyles, Douglas S. |
|
|
20 |
C |
p. 433 |
artikel |
4 |
Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of KITLG and DKK1 genes in glioma SCs in vitro
|
Aslam, Nazneen |
|
|
20 |
C |
p. 147-165 |
artikel |
5 |
A polygenic methylation prediction model associated with response to chemotherapy in epithelial ovarian cancer
|
Zhao, Lanbo |
|
|
20 |
C |
p. 545-555 |
artikel |
6 |
Applications of nuclear-based imaging in gene and cell therapy: Probe considerations
|
Volpe, Alessia |
|
|
20 |
C |
p. 447-458 |
artikel |
7 |
Association between NER pathway gene polymorphisms and neuroblastoma risk in an eastern Chinese population
|
Zhou, Chunlei |
|
|
20 |
C |
p. 3-11 |
artikel |
8 |
A survivin-driven, tumor-activatable minicircle system for prostate cancer theranostics
|
Wang, TianDuo |
|
|
20 |
C |
p. 209-219 |
artikel |
9 |
Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion
|
Robertson, Matthew Glen |
|
|
20 |
C |
p. 659-668 |
artikel |
10 |
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform
|
Ylösmäki, Erkko |
|
|
20 |
C |
p. 459-469 |
artikel |
11 |
Characterization of the fatty acid metabolism in colorectal cancer to guide clinical therapy
|
Ding, Chengsheng |
|
|
20 |
C |
p. 532-544 |
artikel |
12 |
Classification of pediatric gliomas based on immunological profiling: Implications for immunotherapy strategies
|
Wang, Zihao |
|
|
20 |
C |
p. 34-47 |
artikel |
13 |
Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models
|
McAusland, Thomas M. |
|
|
20 |
C |
p. 306-324 |
artikel |
14 |
CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy
|
Pan, Yi Chun |
|
|
20 |
C |
p. 175-186 |
artikel |
15 |
Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma
|
Kubo, Hiroshi |
|
|
20 |
C |
p. 646-658 |
artikel |
16 |
Efficient antitumor effects of a novel oncolytic adenovirus fully composed of species B adenovirus serotype 35
|
Ono, Ryosuke |
|
|
20 |
C |
p. 399-409 |
artikel |
17 |
Eliminating mesothelioma by AAV-vectored, PD1-based vaccination in the tumor microenvironment
|
Tan, Zhiwu |
|
|
20 |
C |
p. 373-386 |
artikel |
18 |
Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer
|
Shu, Runzhe |
|
|
20 |
C |
p. 325-341 |
artikel |
19 |
Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?
|
Liu, Hongliang |
|
|
20 |
C |
p. 240-264 |
artikel |
20 |
Genetic variants in m6A modification core genes are associated with glioma risk in Chinese children
|
He, Jing |
|
|
20 |
C |
p. 199-208 |
artikel |
21 |
HDAC inhibition prevents transgene expression downregulation and loss-of-function in T cell-receptor-transduced T cells
|
Moore, Tamson V. |
|
|
20 |
C |
p. 352-363 |
artikel |
22 |
Inhibition of tumor invasion and metastasis by targeting TGF-β-Smad-MMP2 pathway with Asiatic acid and Naringenin
|
Lian, Guang-Yu |
|
|
20 |
C |
p. 277-289 |
artikel |
23 |
In vivo CART cell imaging: Paving the way for success in CART cell therapy
|
Sakemura, Reona |
|
|
20 |
C |
p. 625-633 |
artikel |
24 |
Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide
|
Arumugam, Arunkumar |
|
|
20 |
C |
p. 596-606 |
artikel |
25 |
IRGM promotes melanoma cell survival through autophagy and is a promising prognostic biomarker for clinical application
|
Tian, Linlu |
|
|
20 |
C |
p. 187-198 |
artikel |
26 |
Knockdown of the DJ-1 (PARK7) gene sensitizes pancreatic cancer to erlotinib inhibition
|
He, Xiangyi |
|
|
20 |
C |
p. 364-372 |
artikel |
27 |
Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma
|
Zalacain, Marta |
|
|
20 |
C |
p. 23-33 |
artikel |
28 |
Metformin enhances anti-cancer effects of cisplatin in meningioma through AMPK-mTOR signaling pathways
|
Guo, Liemei |
|
|
20 |
C |
p. 119-131 |
artikel |
29 |
microRNA-130b-3p contained in MSC-derived EVs promotes lung cancer progression by regulating the FOXO3/NFE2L2/TXNRD1 axis
|
Guo, Quanwei |
|
|
20 |
C |
p. 132-146 |
artikel |
30 |
MicroRNA modification of coxsackievirus B3 decreases its toxicity, while retaining oncolytic potency against lung cancer
|
Liu, Huitao |
|
|
20 |
C |
p. 1-2 |
artikel |
31 |
miR-19a/b promote EMT and proliferation in glioma cells via SEPT7-AKT-NF-κB pathway
|
Wang, Weihan |
|
|
20 |
C |
p. 290-305 |
artikel |
32 |
M2 macrophage-derived exosomal microRNA-155-5p promotes the immune escape of colon cancer by downregulating ZC3H12B
|
Ma, Yu-Shui |
|
|
20 |
C |
p. 484-498 |
artikel |
33 |
Modulation of mTOR and epigenetic pathways as therapeutics in gallbladder cancer
|
Yang, Dong |
|
|
20 |
C |
p. 59-70 |
artikel |
34 |
Molecular profiles of small cell lung cancer subtypes: Therapeutic implications
|
Schwendenwein, Anna |
|
|
20 |
C |
p. 470-483 |
artikel |
35 |
Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma
|
Wirsching, Hans-Georg |
|
|
20 |
C |
p. 166-174 |
artikel |
36 |
Oncolytic activity of naturally attenuated herpes-simplex virus HF10 against an immunocompetent model of oral carcinoma
|
Takano, Gaku |
|
|
20 |
C |
p. 220-227 |
artikel |
37 |
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
|
Ghose, Jayeeta |
|
|
20 |
C |
p. 519-531 |
artikel |
38 |
Oncolytic reovirus-mediated recruitment of early innate immune responses reverses immunotherapy resistance in prostate tumors
|
Annels, Nicola E. |
|
|
20 |
C |
p. 434-446 |
artikel |
39 |
Oncolytic vaccinia virus induces a novel phenotype of CD8+ effector T cells characterized by high ICOS expression
|
Yamashita, Midori |
|
|
20 |
C |
p. 422-432 |
artikel |
40 |
Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer
|
Barton, Kenneth N. |
|
|
20 |
C |
p. 94-104 |
artikel |
41 |
PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer
|
Shen, Hongwei |
|
|
20 |
C |
p. 499-507 |
artikel |
42 |
Real-time visualization of intratumoral necrosis using split-luciferase reconstitution by protein trans-splicing
|
Kagiya, Go |
|
|
20 |
C |
p. 48-58 |
artikel |
43 |
Recombinant oncolytic adenovirus expressing a soluble PVR elicits long-term antitumor immune surveillance
|
Zhang, Hailin |
|
|
20 |
C |
p. 12-22 |
artikel |
44 |
Single-cell RNA-sequencing analyses identify heterogeneity of CD8+ T cell subpopulations and novel therapy targets in melanoma
|
Deng, Weiwei |
|
|
20 |
C |
p. 105-118 |
artikel |
45 |
Structure-based virtual screening identifies an 8-hydroxyquinoline as a small molecule GLI1 inhibitor
|
Dash, Radha Charan |
|
|
20 |
C |
p. 265-276 |
artikel |
46 |
Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes
|
Labani-Motlagh, Alireza |
|
|
20 |
C |
p. 508-518 |
artikel |
47 |
Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism
|
Chen, Ping |
|
|
20 |
C |
p. 228-239 |
artikel |
48 |
The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
|
Zhang, Qian |
|
|
20 |
C |
p. 556-568 |
artikel |
49 |
The lncRNA DLGAP1-AS1/miR-149-5p/TGFB2 axis contributes to colorectal cancer progression and 5-FU resistance by regulating smad2 pathway
|
Qu, Linlin |
|
|
20 |
C |
p. 607-624 |
artikel |
50 |
The long non-coding RNA SNHG4/microRNA-let-7e/KDM3A/p21 pathway is involved in the development of non-small cell lung cancer
|
Wang, Fan |
|
|
20 |
C |
p. 634-645 |
artikel |
51 |
Therapeutic potential of IBP as an autophagy inducer for treating lung cancer via blocking PAK1/Akt/mTOR signaling
|
Bu, Huimin |
|
|
20 |
C |
p. 82-93 |
artikel |
52 |
Tumor-derived exosomal microRNA-7-5p enhanced by verbascoside inhibits biological behaviors of glioblastoma in vitro and in vivo
|
Wang, Huan |
|
|
20 |
C |
p. 569-582 |
artikel |
53 |
Tumor immune microenvironment-based classifications of bladder cancer for enhancing the response rate of immunotherapy
|
Meng, Jialin |
|
|
20 |
C |
p. 410-421 |
artikel |
54 |
Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma
|
Qin, Yixiao |
|
|
20 |
C |
p. 342-351 |
artikel |
55 |
Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis
|
Li, Nuo |
|
|
20 |
C |
p. 583-595 |
artikel |